Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Gerosa

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
Seminars in Arthritis and Rheumatism|June 25, 2025
The effectiveness and safety of rituximab in juvenile idiopathic arthritis: Hints from the ITHACA monocentric registryMaria Rosa Pellico, Marco Pandolfi, Andrea Amati, et al.
Frontiers in Immunology|April 30, 2019
Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid SyndromePaola Adele Lonati, Mariangela Scavone, Maria Gerosa, et al.
Clinical and Experimental Rheumatology|December 19, 2022
Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohortLaura Locatelli, Marta Calatroni, Francesco Reggiani, et al.
Rheumatology (Oxford, England)|August 28, 2012
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications?Rossella Reggia, Tamara Ziglioli, Laura Andreoli, et al.
Clinical and Experimental Rheumatology|September 12, 2024
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experimentLuca Quartuccio, Matteo Piga, Fabiola Atzeni, et al.
Clinical and Experimental Rheumatology|October 23, 2020
Ultrasound assessment of lacrimal glands: a cross-sectional study in healthy subjects and a preliminary study in primary Sjögren's syndrome patientsOrazio De Lucia, Sara Zandonella Callegher, Mirian Veronica De Souza, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2015
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndromeLaura Andreoli, Cecilia B Chighizola, Cecilia Nalli, et al.
Lupus Science & Medicine|July 9, 2026
Real-world experience with personalised belimumab spacing in sustained SLE remission: a multicentre studyAlice Bartoletti, Lorenza Maria Argolini, Giuseppe Alvise Ramirez, et al.
Rheumatology (Oxford, England)|May 23, 2020
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodiesFrancesca Pregnolato, Maria Gerosa, Maria Gabriella Raimondo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2017
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid SyndromeMarisa Benagiano, Maria Gerosa, Jacopo Romagnoli, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Seminars in Arthritis and Rheumatism|June 25, 2025
The effectiveness and safety of rituximab in juvenile idiopathic arthritis: Hints from the ITHACA monocentric registryMaria Rosa Pellico, Marco Pandolfi, Andrea Amati, et al.
Frontiers in Immunology|April 30, 2019
Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid SyndromePaola Adele Lonati, Mariangela Scavone, Maria Gerosa, et al.
Clinical and Experimental Rheumatology|December 19, 2022
Long-term kidney outcome of patients with rheumatological diseases and antineutrophil cytoplasmic antibody-glomerulonephritis: comparison with a primitive ANCA-glomerulonephritis cohortLaura Locatelli, Marta Calatroni, Francesco Reggiani, et al.
Rheumatology (Oxford, England)|August 28, 2012
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications?Rossella Reggia, Tamara Ziglioli, Laura Andreoli, et al.
Clinical and Experimental Rheumatology|September 12, 2024
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experimentLuca Quartuccio, Matteo Piga, Fabiola Atzeni, et al.
Clinical and Experimental Rheumatology|October 23, 2020
Ultrasound assessment of lacrimal glands: a cross-sectional study in healthy subjects and a preliminary study in primary Sjögren's syndrome patientsOrazio De Lucia, Sara Zandonella Callegher, Mirian Veronica De Souza, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2015
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndromeLaura Andreoli, Cecilia B Chighizola, Cecilia Nalli, et al.
Lupus Science & Medicine|July 9, 2026
Real-world experience with personalised belimumab spacing in sustained SLE remission: a multicentre studyAlice Bartoletti, Lorenza Maria Argolini, Giuseppe Alvise Ramirez, et al.
Rheumatology (Oxford, England)|May 23, 2020
EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodiesFrancesca Pregnolato, Maria Gerosa, Maria Gabriella Raimondo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2017
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid SyndromeMarisa Benagiano, Maria Gerosa, Jacopo Romagnoli, et al.
Pageof 12